Last updated on July 2019

A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies


Brief description of study

This is a global, multicenter, open-label safety extension study. Participants receiving single-agent trastuzumab emtansine or trastuzumab emtansine administered in combination with other agents in a Genentech/Roche-sponsored parent study who are active and deriving benefit at the closure of parent study are eligible for continued treatment in this study.

Clinical Study Identifier: NCT00781612

Find a site near you

Start Over

Comp Cancer Centers of Nevada

Los Angeles, CA United States
  Connect »

Central Coast Medical Oncology

Santa Maria, CA United States
  Connect »

UCLA Oncology Office; Oncology

Santa Monica, CA United States
  Connect »

Stanford Cancer Institute

Stanford, CA United States
  Connect »

Kaiser Permanente - Walnut Creek

Walnut Creek, CA United States
  Connect »

University of Colorado

Aurora, CO United States
  Connect »

Kootenai Cancer Center

Post Falls, ID United States
  Connect »

Illinois Cancer Care

Peoria, IL United States
  Connect »

Cancer Center of Kansas

Wichita, KS United States
  Connect »

New England Cancer Specialists

Scarborough, ME United States
  Connect »

Karmanos Cancer Institute

Detroit, MI United States
  Connect »

Minnesota Oncology Hematology, Pa

Minneapolis, MN United States
  Connect »

University of Minnesota.

Minneapolis, MN United States
  Connect »

Mayo Clinic - Rochester

Rochester, MN United States
  Connect »

Capitol Comprehensive CA Care

Jefferson City, MO United States
  Connect »

Mercy Clinic Cancer & Hematology

Springfield, MO United States
  Connect »

St. Barnabas Health Care Sys

Livingston, NJ United States
  Connect »

Clinical Research Alliance

Lake Success, NY United States
  Connect »

NS-Long Island Jewish Hlth Sys

Lake Success, NY United States
  Connect »

Fox Chase Cancer Center

Philadelphia, PA United States
  Connect »

Sarah Cannon Cancer Center

Germantown, TN United States
  Connect »

Vanderbilt Ingram Cancer Ctr

Nashville, TN United States
  Connect »

Texas Oncology

Bedford, TX United States
  Connect »

Millennium Oncology

Houston, TX United States
  Connect »

USO

Plano, TX United States
  Connect »

Cancer Therapy & Research Center

San Antonio, TX United States
  Connect »

US Oncology Research, Inc.

The Woodlands, TX United States
  Connect »

USO - Tyler Cancer Ctr

Tyler, TX United States
  Connect »

Univ of WA Medical Center

Seattle, WA United States
  Connect »

UZ Gent

Gent, Belgium
  Connect »

Grupo Angeles

Guatemala City, Guatemala
  Connect »

National Cancer Center

Gyeonggi-do, Korea, Republic of
  Connect »

Samsung Medical Center

Seoul, Korea, Republic of
  Connect »

Private Health Organization Acibadem Sistina Hospital

Skopje, Macedonia, The Former Yugoslav Republic of
  Connect »

City Oncology Dispensary

St Petersburg, Russian Federation
  Connect »

Ninewells Hospital

Dundee, United Kingdom
  Connect »

Christie Hospital NHS Trust

Manchester, United Kingdom
  Connect »

Mount Vernon Hospital

Middlesex, United Kingdom
  Connect »

Mount Vernon Cancer Centre

Northwood, United Kingdom
  Connect »

US Oncology

Irving, TX United States
  Connect »